Does my patient have multidrug-resistant tuberculosis?

Clinical Infectious Diseases

Volumn 51, Issue 4, 2010, Pages 379-380

  Seung, Kwonjune J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PARTNERS IN HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; BACTERIAL MUTATION; DRUG TREATMENT FAILURE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE; PRIORITY JOURNAL; RISK FACTOR; SHORT COURSE THERAPY; SPUTUM SMEAR; TUBERCULOSIS; BACTERIAL SHEDDING; MICROBIOLOGY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; BACTERIAL SHEDDING; HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77955682311     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655128     Document Type: Note

References (6)

1. Fitzwater SP, Caviedes L, Gilman RH, et al. Prolonged infectiousness of tuberculosis patients in a directly observed therapy shortcourse program with standardized therapy. Clin Infect Dis 2010; 51(4):371-378 (in this issue).
2. Espinal M. What is the "fall and rise" phenomenon and the "sequential regimen"mechanism? In: Friedan TR, ed. Toman's tuberculosis: case detection, treatment, and monitoring: questions and answers. 2nd ed. Geneva, Switzerland: World Health Organization, 2004:200-202.
3. Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione M.C. Frequency of recurrence among MDR-TB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis 2002; 6: 858-864.
4. Cox H, Kebede Y, Allamuratova S, et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med 2006; 3:e384.
5. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization, 2010.
6. Farmer P, Bayona J, Becerra M, et al. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis 1998; 2:869-876.